Climate Change Data

Environmental Metrics

Social Achievements

• Organized awareness program “Do It Today” on organ donation.
• Organized 'No Tobacco Campaign'.

Climate Goals & Targets

Environmental Challenges

• Lower sale of pentavalent vaccine Easyfive-TT to UNICEF/PAHO.
• Non-availability of IPV bulk leading to no sales of IPV vaccine.
• Reduction in prices of products due to price control by NPPA.
• Banning of irrational FDCs by DCGI.
• Expiry of excise duty holiday period at Baddi facilities.

Mitigation Strategies

• Scaling up revenues in vaccine segment by participating in emerging market tenders.
• Continue to focus on cost reduction in various areas of operations, sales and marketing, R&D etc.
• Launch of the pneumococcal vaccine, which is currently under development, is expected by year 2020.
• Launch of the Dengue Vaccine which is currently under development, in next 2 years.
• Launch of several pharmaceutical products in India and ROW markets.
• Commercializing the existing led ANDAs in US and other markets in the next 1-3 years and continue to build the ANDA pipeline for long term future growth.

Supply Chain Management

Climate-Related Risks & Opportunities

Awards & Recognition

• Brand of the Year Award 2011 by Bio-Spectrum
• SILVER BRAND in Chronic Care Therapy by AWACS AIOCD in FY 2015-16
• Prestigious ‘Clarivate Analytics India Innovation Award 2016’ from Thomson Reuters

Environmental Metrics

ESG Focus Areas

• Employee Well-being
• Environment
• Corporate Social Responsibility

Environmental Achievements

• Installed a Briquette Fired Boiler to run with Fire Briquette or Wood Fire instead of Furnace Oil, reducing Sulphur emission.
• Implemented various energy conservation measures like replacing CFL lamps with LED lights, using treated water for irrigation, and installing energy-efficient pumps.

Social Achievements

• Conducted various patient awareness camps on Diabetes, Cancer, Cardiovascular & Osteoporosis diseases, Organ Donation, and lifestyle management.
• Improved market ranking to No. 2 in its covered market (AIOCD AWACS (MAT March 2020) sales data).

Governance Achievements

• Strengthened the Board of Directors with the induction of a nominee director and an independent director.
• Implemented a Vigil Mechanism to encourage reporting of unethical behavior.

Climate Goals & Targets

Environmental Challenges

• Long gestation period on R&D projects.
• High dependence on institutional business in the vaccine segment.
• Revenue concentration on a few products.
• Dependence on a few imported suppliers in drug substance.
• Price control by the government.
• Increasing regulatory compliances and costs.
• Pricing pressure amid intense competition.
• High volatility in currency exchange rates.
• Risk of all R&D initiatives not leading to commercially viable and successful products.
• Impact of COVID-19 pandemic on immunization activities and economic activities.

Mitigation Strategies

• Expanding into private markets in India and ROW countries through strategic tie-ups.
• Reducing dependence on foreign suppliers by developing in-house drug substances.
• Improving plant utilization levels with the registration of pentavalent and hexavalent vaccines in global markets.
• Launching new products in US and ROW markets and through selective contract manufacturing tie-ups.
• Developing in-house drug substances at Lalru.
• Following guidelines prescribed by USFDA and other regulatory agencies.
• Building a strong portfolio, strengthening marketing team, entering into newer markets, identifying strong distributor and marketing partners into newer regions and registering products in more countries.
• Implementing Work from Home for most employees, sanitization of premises, video training sessions, and strict adherence to social distancing norms.

Supply Chain Management

Responsible Procurement

• Standard Operating Procedure for sourcing raw materials
• Periodic audits of vendors

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: National Voluntary Guidelines (NVGs) on Social, Environmental and Economic Responsibilities of Business

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Initiated erection and commissioning of new 6 ton Briquette Fired Boiler (to run with Fire Briquette or Wood Fire) at Baddi to replace Furnace Oil Fired Boilers thereby shifting to renewable energy source and to also reduce Sulphur emission.
• Replacement of CFL lamps, Halogen lamps and conventional tube lights with LED lights at several locations.
• Use of water treated from ETP & STP for plantation & irrigation purposes.

Social Achievements

• Conducted more than 450 A1C camps, 9,000 DDC camps & 16,000 OPD camps by touching over 1,00,000 patients through its “SURAKSHA” initiative.
• Launched 24X7 helpline number with multi-lingual capabilities to support the patients with doorstep delivery of essential medicines.
• Provided essential tools including the masks and sanitizers to health care professionals for their safety and protection.

Governance Achievements

• Adopted a Dividend Distribution Policy
• Constituted the Risk Management Committee

Climate Goals & Targets

Environmental Challenges

• Impact of Covid-19 pandemic on supply chains globally which were affected due to travel restrictions.
• Delays and temporary halts were observed in clinical development pipeline of pharma majors globally and subsequent delay in regulatory approvals as the agencies were preoccupied with regulatory review of Covid-related medications and vaccines.
• Nation-wide lockdowns impacted the movement of people to hospitals and access to clinical services and the spill-over effect was seen in the dip in sales of hospital-administered medications and acute medicines.

Mitigation Strategies

• Formed internal task force to ensure our production and supplies continue unaffected.
• Took appropriate safety measures to create a safe work environment for our employees across manufacturing sites and other offices.
• Took various measures to ensure availability of life-saving medicines to patients in India and international markets.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed